RxDoctor Payments Data

Karishma Harjani, PA

Physician Assistant · Levittown, PANPI 1487344636

Payments from drug & device makers

$4,260in general payments, 2019–2025

Across 247 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$696
  • AstraZeneca$324
  • Pfizer$306
  • Lilly USA, LLC$294
  • Novo Nordisk$286
  • Otsuka America Pharmaceutical, Inc.$284
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$4,260100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,260 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$39,637
Medicare patients
180
Services billed
754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$15,439
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,568
Icosapent Ethyl12$1,188
Aripiprazole11$1,172
Methylprednisolone118$502
Metoprolol Succinate19$492
Atorvastatin Calcium55$491
Levothyroxine Sodium41$490
Metformin Hcl54$468
Albuterol Sulfate HfaAlbuterol Sulfate20$453
Rosuvastatin Calcium11$395
Losartan Potassium31$350
ClopidogrelClopidogrel Bisulfate23$294
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$285
Lisinopril31$274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$68$15,43917 claims
GSKTrelegy Ellipta$156$7,56812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Levittown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →